Related Experiment Video

Updated: Jun 19, 2026

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Destablilization of TRAF6 by DRAK1 Suppresses Tumor Growth and Metastasis in Cervical Cancer Cells

Yuna Park1,2, Kyoungwha Pang1,2, Jinah Park1

  • 1Precision Medicine Research Center, Advanced Institute of Convergence Technology, Seoul National University, Suwon, Gyeonggi-do, Republic of Korea.

Cancer Research
|April 9, 2020
PubMed

Insights

Death-associated protein kinase-related apoptosis-inducing kinase 1 (DRAK1) suppresses cervical cancer by targeting TRAF6 for degradation. This reduces inflammatory signaling, tumor growth, and metastasis, highlighting DRAK1 as a novel therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor growth and metastasis are often driven by inflammatory signaling pathways.
  • The adaptor protein TNF receptor-associated factor 6 (TRAF6) is a key mediator in inflammation, but its role in cancer progression is not fully understood.
  • Understanding the regulation of TRAF6 stability and activity is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of death-associated protein kinase-related apoptosis-inducing kinase 1 (DRAK1) in regulating TRAF6 activity and its impact on cervical cancer progression.
  • To elucidate the molecular mechanisms by which DRAK1 affects TRAF6 stability and inflammatory signaling.
  • To determine the correlation between DRAK1 and TRAF6 expression in cervical cancer tissues.

Main Methods:

  • Investigated the interaction between DRAK1 and TRAF6 using biochemical assays.
  • Assessed the effect of DRAK1 on TRAF6 ubiquitination and degradation.
  • Analyzed the impact of DRAK1 depletion on inflammatory signaling pathways and cytokine production in cervical cancer cells.
  • Examined DRAK1 and TRAF6 expression levels in mouse xenograft models and human cervical cancer tissues.

Main Results:

  • DRAK1 directly binds to TRAF6, preventing its autoubiquitination and promoting autophagy-mediated degradation.
  • Depletion of DRAK1 leads to increased TRAF6 levels, enhanced IL-1β signaling, and elevated proinflammatory cytokine production.
  • DRAK1 is significantly underexpressed in metastatic cervical cancers and inversely correlates with TRAF6 expression.
  • DRAK1 inhibits inflammatory signaling-mediated tumor growth and metastasis in advanced cervical cancer cells.

Conclusions:

  • DRAK1 acts as a novel negative regulator of TRAF6, inhibiting inflammatory signaling in cervical cancer.
  • Targeting DRAK1 could be a potential therapeutic strategy to suppress inflammation-driven cervical cancer progression and metastasis.
  • DRAK1's role in TRAF6 degradation offers new insights into the molecular mechanisms underlying cancer-associated inflammation.

More Related Videos

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...